{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:01Z","timestamp":1786118941381,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,26]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To understand the changes in opioid cessation surrounding the release of CDC guidelines and changes in state Medicaid coverage at the individual patient level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study used a 20% national sample of Medicare beneficiaries between 2013 and 2018 with at least 90 days of consecutive opioid use in the first year of either of 2 study periods (2013\u20132015 or 2016\u20132018). Cessation of opioid use was assessed in year 3 of each period by generalized linear mixed models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Opioid cessation rates were higher in period 2 (11.2%) compared to period 1 (10.1%). Adjusted for beneficiary characteristics, those in period 2 had 1.07 times the odds of cessation (95% CI: 1.05\u20131.09) compared to those in period 1. Additionally, the increase in opioid cessation over time was larger in states with Medicaid expansion compared to those without.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The increase in opioid cessation after 2016 suggests the potential effects of the CDC guidelines on opioid prescribing and underscores the need for further research on the relationship between opioid cessation and subsequent change in pain control, quality of life, and opioid toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000029944","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T10:03:03Z","timestamp":1661853783000},"page":"e29944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["National patterns of cessation of prescription opioids among Medicare beneficiaries, 2013\u20132018"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1473-1766","authenticated-orcid":false,"given":"Jordan","family":"Westra","sequence":"first","affiliation":[{"name":"Office of Biostatistics, University of Texas Medical Branch, Galveston, TX, USA"},{"name":"Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaila","family":"Raji","sequence":"additional","affiliation":[{"name":"Division of Geriatrics and Palliative Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA"},{"name":"Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-fang","family":"Kuo","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, University of Texas Medical Branch, Galveston, TX, USA"},{"name":"Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015.","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20250707","first-page":"49661","article-title":"Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.","volume":"79","year":"2014","journal-title":"Fed Regist"},{"key":"R5-20250707","first-page":"65","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain \u2013 United States, 2016.","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/jgs.15332","article-title":"Opioid prescriptions in older medicare beneficiaries after the 2014 federal rescheduling of hydrocodone products.","volume":"66","author":"Kuo","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"R7-20250707","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0033354919892638","article-title":"Opioid prescribing among adults with disabilities in the United States after the 2014 federal hydrocodone rescheduling regulation.","volume":"135","author":"Liaw","year":"2019","journal-title":"Public Health Rep"},{"key":"R8-20250707","first-page":"1","article-title":"Opioid prescribing patterns and overdose deaths in Texas.","volume":"0","author":"Champagne-Langabeer","year":"2019","journal-title":"Subst Abuse"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ANA.0000000000000682","article-title":"Opioid utilization in geriatric patients after operation for degenerative spine disease.","volume":"33","author":"Nguyen","year":"2021","journal-title":"J Neurosurg Anesthesiol"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/j.pain.0000000000000516","article-title":"Trends and predictors of opioid use following total knee and total hip arthroplasty.","volume":"157","author":"Goesling","year":"2016","journal-title":"Pain"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3171\/2020.3.SPINE20111","article-title":"Opioid use after adult spinal deformity surgery: patterns of cessation and associations with preoperative use.","volume":"33","author":"Ren","year":"2020","journal-title":"J Neurosurg Spine"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"g1251","DOI":"10.1136\/bmj.g1251","article-title":"Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.","volume":"348","author":"Clarke","year":"2014","journal-title":"BMJ"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/BRS.0000000000003446","article-title":"Duration and dosage of opioids after spine surgery: implications on outcomes at 1 year.","volume":"45","author":"Hills","year":"2020","journal-title":"Spine"},{"key":"R16-20250707","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1213\/ANE.0b013e31825c049f","article-title":"A pilot cohort study of the determinants of longitudinal opioid use after surgery.","volume":"115","author":"Carroll","year":"2012","journal-title":"Anesth Analg"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.pmn.2018.04.007","article-title":"Predictors of weeks to opioid cessation after lumbar fusion: a prospective cohort study.","volume":"19","author":"Lall","year":"2018","journal-title":"Pain Manag Nurs Off J Am Soc Pain Manag Nurses"},{"key":"R18-20250707","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the united states before and after the centers for disease control and prevention\u2019s 2016 opioid guideline.","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"R19-20250707","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamainternmed.2018.6989","article-title":"County-level opioid prescribing in the united states, 2015 and 2017.","volume":"179","author":"Guy","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R20-20250707","doi-asserted-by":"crossref","first-page":"e2027481","DOI":"10.1001\/jamanetworkopen.2020.27481","article-title":"Comparison of opioids prescribed for patients at risk for opioid misuse before and after publication of the centers for disease control and prevention\u2019s opioid prescribing guidelines.","volume":"3","author":"Scherrer","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R21-20250707","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2019.2563","article-title":"Opioid and benzodiazepine coprescribing in the United States before and after US food and drug administration boxed warning.","volume":"76","author":"Zhang","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"R23-20250707","doi-asserted-by":"crossref","first-page":"e1915638","DOI":"10.1001\/jamanetworkopen.2019.15638","article-title":"Association of disability with mortality from opioid overdose among US medicare adults.","volume":"2","author":"Kuo","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R24-20250707","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions.","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"key":"R25-20250707","doi-asserted-by":"crossref","first-page":"108282","DOI":"10.1016\/j.jsat.2021.108282","article-title":"Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in medicare beneficiaries.","volume":"124","author":"Kuo","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R26-20250707","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants United States, 2015-2016.","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000029944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:12:07Z","timestamp":1786036327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000029944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":21,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029944","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}